Search Results for 'chronic and debilitating disease'
1 results found.
Elan’s Tysabri lowers Crohn’s hospitalisations
Athlone-based pharmaceutical company, Elan, and its US partner Biogen have announced that their drug Tysabri has been proven to significantly reduce the rate of hospitalisation of patients with moderate-to-severe Crohn’s disease.
